According to a new market report published by Lucintel, the future of the cold plasma market looks promising with opportunities in wound healing, blood coagulation, dentistry, and cancer treatment applications. The cold plasma market is expected to grow with a CAGR of 16% from 2019 to 2024. The major drivers for this market are environment-friendliness and other benefits of cold plasma techniques, innovations in textile production and other end use industries, food safety concerns, and increasing use of cold plasma in meat and poultry packaging decontamination.
In this market, atmospheric cold plasma and low pressure cold plasma are the major product segments. Atmospheric cold plasma is the largest product segment of the cold plasma market.
Europe will remain the largest region over the forecast period due to the presence of a large number of cold plasma companies and growing research and development work in the European countries.
Nordson, Bovie Medical, Plasmatreat GmbH, P2I, ADTEC Plasma Technology, Enercon, Neoplas Tools GmbH, Tantec A/S, Europlasma, and Henniker Plasma Treatment are among the major manufacturers of cold plasma.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the cold plasma market by product, application, and region. Lucintel has prepared a comprehensive research report titled " Cold Plasma Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategies, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the cold plasma market by product, application, and region as follows:
By Product [$M shipment analysis for 2013 – 2024]:
• Atmospheric Cold Plasma
• Low Pressure Cold Plasma
By Application [$M shipment analysis for 2013 – 2024]:
• Wound Healing
• Blood Coagulation
• Dentistry
• Cancer Treatment
• Other
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United kingdom
o Germany
o France
o Italy
o Spain
• Asia Pacific
o China
o India
o Japan
• ROW
o Brazil
A report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising potential, high growth opportunities for the cold plasma market by product (atmospheric cold plasma and low pressure cold plasma), application (wound healing, blood coagulation, dentistry, cancer treatment, and other), and region (North America, Europe, Asia Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the cold plasma market?
Q.5. What are the business risks and threats to the cold plasma market?
Q.6. What are emerging trends in the cold plasma market and the reasons behind them?
Q.7. What are some changing demands of customers in the cold plasma market?
Q.8. What are the new developments in the cold plasma market? Which companies are leading these developments?
Q.9. Who are the major players in the cold plasma market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in the cold plasma market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities did take place in the last five years in the cold plasma market?